Clinical Trial Update: Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder [Phase 2, Phase 3]

View source ↗

Summary

This entry reports the completion of Phase 2 and Phase 3 clinical trials evaluating buspirone for treating autistic disorder in children aged 2 to 6 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: Chugani, Diane C. | Conditions: Autistic Disorder | Phase 2, Phase 3 | Status: COMPLETED